Salud
La vacunación con Novavax en la UE ha comenzado lentamente
Demand for Novavax’s COVID-19 vaccine was underwhelming in the core countries of the European Union during the initial rollout. More than 85% of adults in
Japón: los suicidios entre mujeres aumentan por segundo año
The number of women who commit suicide in Japan rose for the second year in a row in 2021, although the total number of people
Estados Unidos no aprueba AstraZeneca para enfermedades nasales crónicas
AstraZeneca said the US regulator has refused to approve the asthma drug Fasenra for the treatment of chronic rhinosinusitis with nasal polyps, a condition characterized
India comenzará a vacunar a los niños contra el COVID-19
India will begin vaccinating children aged 12 to 14 against COVID-19 from March 16, the country’s health ministry said as schools reopen across the country
Hong Kong ha reportado 26,908 nuevos casos de COVID
Hong Kong health authorities reported 26,908 new cases of COVID-19 on Monday, of which 14,868 were confirmed using a self-report platform where residents can register
Muere hombre con trasplante de corazón de cerdo
A 57-year-old man with terminal heart disease, who made history as the first person to receive a genetically modified pig heart, has died at the
Hong Kong planea reabrir la ciudad después de hacer frente al brote de COVID
Hong Kong leader Carrie Lam said now is not the time to lift the flight ban from nine countries, including the US and UK, and
Hong Kong reporta 58.767 nuevos casos de COVID
Las autoridades sanitarias de Hong Kong informaron este miércoles de 25.991 nuevos casos de COVID-19 confirmados mediante pruebas de ácido nucleico y otros 32.776 confirmados mediante pruebas rápidas de antígenos.
COVID-19 puede causar encogimiento del cerebro y pérdida de memoria
A US study has shown that COVID-19 can cause a decrease in brain size, a reduction in gray matter in areas that control emotions and
Moderna está desarrollando vacunas contra 15 patógenos
Moderna said it plans to develop and begin trials of vaccines by 2025 that target 15 of the world’s most worrying pathogens. The company also